Is The Chemours Co. overvalued or undervalued?

As of 5 August 2025, The Chemours Co. has moved from a very attractive to a risky valuation grade. The company appears to be overvalued given its current metrics. The P/E ratio stands at 12, while the EV to EBITDA ratio is 7.55, and the PEG ratio is exceptionally low at 0.06, indicating potential overvaluation relative to growth expectations.
In comparison to its peers, The Chemours Co. has a P/E ratio that is significantly lower than Westlake Corp. at 82.20 and Albemarle Corp. which has a negative P/E ratio. This suggests that while Chemours may be facing challenges, its valuation metrics are not as favorable as some competitors. Additionally, the company's recent stock performance shows a decline of 5.14% over the past year, contrasting sharply with the S&P 500's gain of 17.14%, further reinforcing the notion of overvaluation.